Penserra Capital Management LLC Cytokinetics Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$34.35 - $46.38 $65,608 - $88,585	-1,910 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$18.54 - $35.74 $5,098 - $9,828	275 Added 16.82%	1,910 $68,000
Q2 2021 Aug 12, 2021	BUY	$19.79 - $26.99 $593 - $809	30 Added 1.87%	1,635 $32,000
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $371 - $513	-20 Reduced 1.23%	1,605 $37,000
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $15,580 - $29,210	1,021 Added 169.04%	1,625 $33,000
Q3 2020 Nov 13, 2020	BUY	$20.58 - $28.96 $12,430 - $17,491	604 New	604 $13,000

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.85B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.